• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS SARS-COV-2 IGM; VIDAS® SARS-COV-2 IGM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS SARS-COV-2 IGM; VIDAS® SARS-COV-2 IGM Back to Search Results
Catalog Number 423833
Device Problem False Positive Result (1227)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of obtaining a false positive result for a patient sample when using vidas® sars-cov-2 igm (9com) 60t (ref.423833, lot 1008356180, expiry date: 01-oct-2021) on their vidas® instrument serial number (b)(4).The customer obtained the following results for a patient¿s sample with vidas sars-cov-2 igm (9com) 60t, lot 1008356180: initial testing on (b)(6) 2020: 5.31 (positive).Re-testing on (b)(6) 2020: 5.00 (positive).The results obtained from two other laboratories for this same patient¿s sample were negative: on (b)(6) 2020 (euroimmune assay): igm= 0.13, cut off 0.8 (negative).On (b)(6) 2021, with chorus sars-cov-2 igm: igm = 0.5 cut off 0.9 (negative).To be noted, all testing was performed from one sample collection.The customer reported that the patient did not have clinical signs of covid-19.The patient had been hospitalized from (b)(6) 2020 to (b)(6) 2020, the result of a ct scan was negative for pulmonary signs of covid-19 and two pcr tests performed were also negative.According to the hospital report, the patient had bacterial pneumonia.There is no indication or report from the laboratory that the discrepant results led to any adverse event related to the patient's state of health.It is noted that the results were reported to the patient.A biomérieux internal investigation has been initiated.Reference 423833 is not sold or distributed in the united states.However, u.S-only product reference, 423833-01, has the same formulation and physical properties as reference 423833.
 
Manufacturer Narrative
This report was initially submitted following notification from a customer in italy regarding a false positive result for a patient sample when using vidas® sars-cov-2 igm (9com) 60t (ref.423833, lot 1008356180, expiry date: 01-oct-2021) on their vidas® instrument (serial number (b)(6) ).The results obtained from two other laboratories for this same patient¿s sample were negative.The customer¿s sample was not available for testing for the investigation.The analysis of the batch history records of vidas® sars cov-2 igm batch 1008356180 / 211001-0 showed no anomalies during the manufacturing, quality control, and packaging processes.Three (3) internal samples with the targets close to the cut off at 0.75, 1.71, and 2.51 test values were tested on the retain kit of vidas® sars cov-2 igm batch 1008356180 / 211001-0.No deviations were observed from the lot since its release.Five (5) samples collected before the pandemic (so expected negative) were also tested on the retain kit of vidas® sars cov-2 igm batch 1008356180 / 211001-0.All the samples gave a negative result.The investigation did not reproduce the vidas® sars cov-2 igm positive result obtained by the customer.Without the customer's sample biomerieux cannot further investigate on the potential interference.The positive result could be due to the an interference (such as-but not limited to- rheumatoid factor, anti-nuclear antibody).The package insert of vidas® sars cov-2 igm assay states the following at section limitations of the method: "the individual immune response following sars-cov-2 infection varies considerably and might give different results with assays from different manufacturers.Results of assays from different manufacturers should not be used interchangeably." according to the information mentioned above, there is no reconsideration of the performance for vidas® sars cov-2 igm ref.423833 batch 1008356180 / 211001-0.See section h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS SARS-COV-2 IGM
Type of Device
VIDAS® SARS-COV-2 IGM
Manufacturer (Section D)
BIOMERIEUX SA
376 chemin de l orme
marcy l etoile 69280
FR  69280
MDR Report Key11331756
MDR Text Key239752776
Report Number8020790-2021-00012
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
PMA/PMN Number
UNCLASSIFIED
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 04/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/01/2021
Device Catalogue Number423833
Device Lot Number1008356180
Was Device Available for Evaluation? No
Date Manufacturer Received03/30/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-